![](https://geistlich.us/wp-content/uploads/clinical-case-bg.jpg)
CLINICAL CASE
![](https://geistlich.us/wp-content/uploads/1-dragan_7.png)
![](https://geistlich.us/wp-content/uploads/1-dragan_1.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_2.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_4.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_5.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_6.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_8.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_9.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_10.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_11.png)
![](https://geistlich.us/wp-content/uploads/1-dragan_12.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_13.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_14-scaled.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_15-scaled.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_16.jpg)
![](https://geistlich.us/wp-content/uploads/1-dragan_17.jpg)
Download our new eBook and learn how to 4C predictability
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
Geistlich unveils vallos®, a full line of allograft granules and fibers. Discover vallos®